Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03307330 · ClinicalTrials.gov registry record

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea

A clinical trial of Obstructive Sleep Apnea of Adult, sponsored by Mayo Clinic.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT03307330 is a study of Obstructive Sleep Apnea of Adult that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 510-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03307330, a study of Obstructive Sleep Apnea of Adult, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue is likely involved in developing cardiovascular disease. The purpose of this study is to see how sleep apnea changes fat tissue.

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2018-01-08
Est. Completion 2029-12

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03307330

The ClinicalTrials.gov registry entry for NCT03307330 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 510-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (76% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea of Adult appearing as the primary indexed condition, and to 0 interventions.

NCT03307330 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03307330 about?

NCT03307330 is a clinical study titled "A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea". Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue is likely involved in developing cardiovascular disease. The purpose of this study is to see how sl...

What is the current status of trial NCT03307330?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2018-01-08. Estimated completion is 2029-12.

What conditions does trial NCT03307330 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea of Adult.

Who is sponsoring clinical trial NCT03307330?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03307330 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea of Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.